(Total Views: 478)
Posted On: 01/20/2021 1:24:31 AM
Post# of 148900
Calstang,
The change is that the primary endpoint will now be ventilator free survival.
The old metric was time to clinical improvement, with ventilator free survival a secondary endpoint.
Success will be achieved if fewer patients on lenzilumab die or end up on ventilators than on the placebo arm.
The change is that the primary endpoint will now be ventilator free survival.
The old metric was time to clinical improvement, with ventilator free survival a secondary endpoint.
Success will be achieved if fewer patients on lenzilumab die or end up on ventilators than on the placebo arm.
(0)
(0)Scroll down for more posts ▼
